---
title: "Huatai Securities raises the target price for Beijing Enterprises to 38.29 yuan, with non-net profit growth and dividend plans likely to drive valuation recovery"
description: "Huatai Securities raised the target price of BEIJING ENT to RMB 38.29, believing that the growth in net profit excluding non-recurring items and a clear dividend plan will drive the company's valuatio"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/255710295.md"
published_at: "2025-09-03T03:52:05.000Z"
---

# Huatai Securities raises the target price for Beijing Enterprises to 38.29 yuan, with non-net profit growth and dividend plans likely to drive valuation recovery

> Huatai Securities raised the target price of BEIJING ENT to RMB 38.29, believing that the growth in net profit excluding non-recurring items and a clear dividend plan will drive the company's valuation recovery. The company reported a 5.2% year-on-year increase in revenue and an 8.1% increase in net profit in the first half of the year, which is basically in line with expectations. Huatai Securities maintains a "Buy" rating and slightly lowers the 2023 earnings forecast by 0.1% to RMB 5.41 billion, while raising the earnings forecasts for 2026 and 2027 by 0.4% each

Huatai Securities published a research report indicating that BEIJING ENT (00392.HK) saw a 5.2% year-on-year increase in revenue for the first half of the year, with net profit rising by 8.1%, which is basically in line with expectations; the non-recurring net profit increased by 4.1%, and an interim dividend of HKD 0.85 was declared. The firm believes that the growth in non-recurring net profit and a clear dividend plan may drive the company's valuation recovery, maintaining a "Buy" rating, with the target price raised from RMB 34.02 to RMB 38.29.

The firm slightly lowered its earnings forecast for BEIJING ENT this year by 0.1% to RMB 5.41 billion, while raising the earnings forecasts for 2026 and 2027 by 0.4% each, to RMB 5.7 billion and RMB 5.94 billion, respectively

### Related Stocks

- [00392.HK - BEIJING ENT](https://longbridge.com/en/quote/00392.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Huatai Securities Completes HK$10 Billion Zero Coupon Convertible Bond Issue | Huatai Securities Co. Ltd. has successfully issued HK$10 billion in zero coupon convertible bonds due 2027. The net proc | [Link](https://longbridge.com/en/news/275441643.md) |
| Huatai Securities to Raise HK$10 Billion via Zero Coupon Convertible Bonds for Global Expansion | Huatai Securities Co. plans to raise HK$10 billion through zero coupon convertible bonds due 2027. The bonds will be con | [Link](https://longbridge.com/en/news/274571291.md) |
| Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | [Link](https://longbridge.com/en/news/276056763.md) |
| Huatai Securities platziert Nullkupon-Wandelanleihen über 10 Milliarden HK-Dollar | Huatai Securities Co. Ltd. has announced the successful placement of zero-coupon convertible bonds maturing in 2027, tot | [Link](https://longbridge.com/en/news/275441638.md) |
| 08:38 ETN3on Teams Up With Doich Foods in New Brand Partnership Bridging Culture, Community, and Food | N3on, a popular content creator, has partnered with Doich Foods in a brand collaboration that emphasizes cultural connec | [Link](https://longbridge.com/en/news/275765162.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
